We are the voice of the home and alternate site infusion
community and the patients we serve
While Congress intended to create a comprehensive Medicare home infusion benefit for Part B DME drugs in the 21st Century Cures Act, flawed implementation by CMS has led to major access issues for Medicare beneficiaries.
Medicare’s coverage of home infusion therapy is limited. Only about 40 drugs therapies are covered under the Part B DMEPOS benefit, leaving the vast majority of home infused-drugs covered by Part D prescription drugs plan.
NHIA has developed recommendations for commercial, Medicaid and Medicare Advantage payors to reduce administrative burden and remove barriers to accessing certain infusion services.
NHIA represents and advances the interests of organizations that provide medically necessary infusion therapies and products to patients in alternate sites of care. As part of the association’s efforts to advance the industry, we monitor and advocate on a range of important health care issues. We are focused on clinical and business best-practices that may be subject to legislation, regulation, accreditation, practices of health plans/third party payers, and more. Learn more about the issues impacting home and alternate site infusion and how to use your voice to ensure all patients have access to high quality infusion services so they can lead healthy, independent lives.
The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to
An independent analysis by Magnolia Market Access estimates that changes proposed by NHIA to the Preserving Patient Access to Home Infusion Act to expand Medicare Part B home infusion therapy services coverage to anti-infectives, and
A diverse group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across
Momentum has been building for legislators to address Medicare’s broken home infusion benefit as part of a year-end legislative package. After considerable engagement from NHIA, the groundwork has been laid for Congress to pass the
